Collectively, these findings and other previous report demonstrated that METTL3 can activate Notch pathway and facilitate glioma occurrence through regulating its direct targets NOTCH3, DLL3, and HES1, and Notch pathway genes may serve as the potential treatment targets for glioma. The gene discussed is DLL3; the disease is central nervous system cancer.